DiaMedica Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 130.7 | 69.3 | 107.6 | 119.8 | – | – | – | – | – | – | – | – | – | – | – | 4,068.2 | 356.5 | 475.4 | 445.8 | 1,545.3 | – | 3.4 | 3.4 | 3.7 | 5.8 | 16.8 | 11.8 | 12.1 | 24.8 | – | – | – | |
| 11.9 | 8.5 | 4,383.5 | 32.6 | – | 37.9 | 9.4 | 57.7 | 49.0 | 2.0 | 3.9 | 5.1 | 2.6 | 8.4 | 2.8 | 8.7 | 2.4 | 6.5 | 7.5 | 4.2 | 1.6 | 1.6 | 1.6 | 1.4 | 0.9 | 1.3 | 1.5 | 2.0 | 1.8 | 2.1 | 2.3 | 2.1 | 3.7 | 5.7 | 4.8 | 6.2 | 6.6 | 6.7 | 7.7 | 9.8 | |
| – | – | – | – | – | – | – | – | 123.0 | 35.7 | 102.5 | 114.0 | – | – | – | – | – | – | – | – | – | – | – | 3,834.0 | 325.9 | 423.0 | 422.5 | 1,469.5 | – | 3.3 | 3.4 | 3.3 | 5.7 | 16.5 | 11.6 | 11.8 | 24.6 | – | – | – | |
| -10.9% | -28.7% | -14.8% | -18.7% | -11.6% | -12.9% | -9.1% | -4.3% | -7.3% | -16.6% | -14.8% | -16.3% | -36.2% | -14.2% | -24.4% | -7.1% | -11.5% | -5.5% | -6.1% | -14.0% | -16.4% | -17.4% | -17.9% | -23.2% | -36.6% | -27.4% | -32.3% | -13.1% | -18.0% | -17.6% | -19.1% | -17.3% | -10.8% | -9.6% | -13.9% | -15.3% | -8.1% | -7.8% | -8.5% | -8.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | -448.2% | – | – | – | – | – | – | – | – | – | – | – | -53,569.2% | -3,994.4% | -3,994.4% | -6,224.7% | -13,519.7% | – | -50.0% | -32.1% | -16.8% | -22.4% | -50.1% | -50.1% | -50.1% | -0.3% | – | – | – | |
| – | – | – | – | – | – | – | – | -997.4% | -1,109.4% | -1,695.6% | -1,853.7% | – | – | – | – | – | – | – | – | – | – | – | -104,323.1% | -14,914.6% | -15,731.5% | -17,961.8% | -22,846.1% | – | -69.0% | -69.7% | -72.6% | -78.2% | -193.3% | -210.7% | -227.9% | -243.5% | – | – | – | |
| – | – | – | – | – | – | – | – | -1,122.9% | -1,146.8% | -1,680.9% | -1,462.3% | – | – | – | – | – | – | – | – | – | – | – | -104,323.1% | -14,798.9% | -15,366.3% | -17,348.3% | -21,788.2% | – | -62.8% | -62.5% | -64.5% | -70.4% | -177.1% | -195.6% | -214.3% | -231.3% | – | – | – | |
| – | – | – | – | – | – | – | – | -960.6% | -1,149.2% | -1,588.8% | -1,956.2% | – | – | – | – | – | – | – | – | – | – | – | -94,223.1% | -13,039.3% | -13,024.7% | -14,382.0% | -20,173.7% | – | -60.8% | -65.9% | -64.2% | -63.2% | -160.1% | -163.7% | -186.1% | -201.6% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -142.1% | -179.5% | -60,314.1% | -510.5% | – | -533.2% | -74.6% | -411.2% | -421.0% | -33.7% | -60.4% | -62.5% | -95.2% | -139.8% | -73.7% | -87.2% | -35.5% | -47.3% | -58.3% | -70.3% | -30.9% | -30.9% | -33.1% | -36.0% | -37.5% | -43.0% | -57.1% | -27.7% | -32.3% | -38.0% | -41.6% | -37.3% | -45.3% | -60.0% | -79.5% | -108.9% | -61.8% | -58.4% | -74.3% | -97.9% | |
| -73.9% | -119.4% | -298.6% | -191.0% | -360.5% | -236.4% | -44.7% | -94.3% | -104.3% | -31.3% | -54.2% | -57.1% | -83.6% | -117.6% | -68.4% | -78.1% | -33.8% | -43.8% | -55.4% | -65.6% | -29.9% | -29.8% | -31.9% | -34.5% | -35.6% | -39.8% | -51.1% | -26.7% | -30.9% | -35.8% | -39.1% | -35.0% | -41.3% | -52.7% | -69.5% | -94.0% | -56.0% | -53.4% | -66.1% | -83.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -3.0 | -1.7 | -0.9 | -1.5 | -0.9 | -1.4 | -6.7 | -5.7 | -3.9 | -17 | -2.6 | -2.9 | -4.7 | -3.8 | -3.2 | -4.9 | -9.7 | -7.3 | -3.3 | -2.2 | -16 | -4.7 | -3.0 | -3.0 | -2.7 | -4.7 | -2.1 | -5.8 | -2.2 | -4.5 | -2.0 | -14 | -4.0 | -2.9 | -2.5 | -4.0 | -3.2 | -16 | -4.8 | -5.0 | |
| 52.0% | 66.5% | 0.5% | 37.4% | -3.0% | 44.3% | 59.9% | 22.9% | 24.8% | 92.8% | 89.8% | 91.4% | 87.9% | 84.1% | 92.7% | 89.6% | 95.2% | 92.6% | 95.0% | 93.3% | 96.7% | 96.6% | 96.6% | 96.1% | 94.7% | 92.5% | 89.4% | 96.3% | 95.7% | 94.3% | 94.1% | 94.1% | 91.3% | 87.9% | 87.4% | 86.3% | 90.5% | 91.4% | 89.0% | 85.2% | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.48 | -0.47 | -0.58 | -0.63 | -0.61 | -0.70 | -0.54 | -0.77 | -0.72 | -0.48 | -0.70 | -0.61 | -0.77 | -0.81 | -0.75 | -0.70 | -0.63 | -0.74 | -0.72 | -0.76 | -0.76 | -0.71 | -0.51 | -0.51 | -0.50 | -0.52 | -0.58 | -0.61 | -0.47 | -0.51 | -0.51 | -0.52 | -0.51 | -0.57 | -0.63 | -0.69 | -0.64 | -0.70 | -0.65 | -0.70 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 | 0.81 | 0.81 | 0.72 | 0.32 | 0.32 | 0.32 | 0.28 | 0.00 | 0.00 | 0.00 | |
| 0.34 | 0.26 | 0.00 | 0.12 | -0.01 | 0.13 | 0.72 | 0.19 | 0.17 | 1.42 | 1.16 | 0.98 | 0.81 | 0.58 | 1.02 | 0.80 | 1.78 | 1.56 | 1.23 | 1.08 | 2.47 | 2.31 | 1.54 | 1.43 | 1.33 | 1.20 | 1.02 | 2.19 | 1.47 | 1.35 | 1.22 | 1.40 | 1.12 | 0.95 | 0.79 | 0.63 | 1.04 | 1.19 | 0.88 | 0.71 | |
| -0.44 | -0.63 | -0.62 | -0.75 | -0.70 | -0.65 | -0.62 | -0.47 | -0.62 | -0.48 | -0.66 | -0.82 | -0.76 | -0.69 | -0.68 | -0.49 | -0.48 | -0.55 | -0.56 | -0.63 | -0.66 | -0.64 | -0.45 | -0.46 | -0.44 | -0.44 | -0.48 | -0.56 | -0.47 | -0.49 | -0.54 | -0.52 | -0.46 | -0.52 | -0.53 | -0.60 | -0.56 | -0.62 | -0.58 | -0.59 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.